Skip to main content

Difficile clinical trials at UCSD
1 in progress, 0 open to new patients

  • Optimal Treatment for Recurrent Clostridium Difficile

    Sorry, not currently recruiting here

    The purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the treatment of recurrent Clostridium difficile infection.

    San Diego, California and other locations